Op-Ed: Beat Back Ebola through Stronger Collaboration, Action and Infrastructure

Read more

Need for Support Increases in DRC Ebola Outbreak—CDC Foundation Responds

Read more

Ebola Outbreak Response in DRC Demonstrates Importance of Global Health Security

Read more

We Must All Work Together to Fight Ebola in DRC

Read more

The Survivors: Rebuilding Lives after Ebola

Read more

Ebola: People + Public Health + Political Will

Read more

Evaluation of Rabies Virus Vectored Ebola Vaccine

907
Ebola
Evaluation of Rabies Virus Vectored Ebola Vaccine
Pennsylvania, USA
United States of America
To design and evaluate a thermostable Rabies Virus Vectored Ebola Vaccine. As Ebola exists in some of the poorest parts of the world where the climate is tropical, the development of a thermostable vaccine could be cost-effective, resulting in greater long-term vaccine stability in high ambient temperatures.
Thomas Jefferson University (National Institutes of Health)
CDC's National Center for Emerging and Zoonotic Infectious Diseases

Charlie Stokes: A Closer Look

Read more

CDC: A Year In Review, A Look Into 2016

Read more

Giving Tuesday 2015: Health Connects Us All

Read more
Subscribe to Ebola